These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 4056529)
1. [Tissue polypeptide antigen as a tumor marker for gynecologic malignancies]. Inoue M; Fujita Y; Abe Y; Inoue Y; Ueda G; Tanizawa O; Minagawa J; Yamada T; Ohashi K; Ozaki M Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1799-805. PubMed ID: 4056529 [TBL] [Abstract][Full Text] [Related]
2. The clinical value of tissue polypeptide antigen in patients with gynecologic tumors. Inoue M; Inoue Y; Hiramatsu K; Ueda G Cancer; 1985 Jun; 55(11):2618-23. PubMed ID: 3995474 [TBL] [Abstract][Full Text] [Related]
3. [The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor]. Inoue M; Inoue Y; Hiramatsu K; Tanaka Y; Yamasaki M; Ueda G; Minagawa J; Ozaki M; Yanagida T; Nishino H Nihon Sanka Fujinka Gakkai Zasshi; 1984 May; 36(5):779-84. PubMed ID: 6736725 [TBL] [Abstract][Full Text] [Related]
4. Clinical value of sialyl Tn antigen in patients with gynecologic tumors. Inoue M; Ogawa H; Nakanishi K; Tanizawa O; Karino K; Endo J Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728 [TBL] [Abstract][Full Text] [Related]
5. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies]. Ueda M; Sudo N; Furuya M; Arakawa O; Ikarashi T Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2361-8. PubMed ID: 3001201 [TBL] [Abstract][Full Text] [Related]
6. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies]. Nakajima H; Hirata T; Norisugi T; Furuno K; Ikehata N; Utsunomiya A; Kobayashi K; Negishi Y; Akiya K Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688 [TBL] [Abstract][Full Text] [Related]
7. [The clinical value of tissue polypeptide antigen in ovarian carcinoma]. Wu L; Sun J; Wang X Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):92-4. PubMed ID: 10682428 [TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin. Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639 [TBL] [Abstract][Full Text] [Related]
9. Sialyl Lewis-Xi antigen in patients with gynecologic tumors. Inoue M; Shimizu C; Sasagawa T; Shimizu H; Saito J; Tanizawa O Obstet Gynecol; 1989 Jan; 73(1):79-83. PubMed ID: 2909045 [TBL] [Abstract][Full Text] [Related]
10. [The clinical significance of serum sialyl Tn antigen levels in patients with gynecologic tumors]. Shimizu C; Inoue M; Ogawa H; Ueda G; Tanizawa O Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1537-42. PubMed ID: 2273309 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms]. Yabushita H; Masuda T; Hattori A; Noguchi M; Ito Y; Nakanishi M; Ishihara M Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1883-92. PubMed ID: 2997349 [TBL] [Abstract][Full Text] [Related]
12. [Tissue polypeptide antigen (TPA) in urological malignancies. I. S-TPA in bladder cancer patients]. Akiyama T; Tsujihashi H; Boku E; Nagai N; Matsuura T; Iguchi M; Yachiku S; Kurita T Hinyokika Kiyo; 1983 Dec; 29(12):1635-40. PubMed ID: 6677110 [TBL] [Abstract][Full Text] [Related]
13. [Importance of the tissue polypeptide antigen level in neoplastic patients. Its correlation with other tumor markers]. Ruibal A; Durán P; Lafuerza A; Bodi R; Solé LA; Rubio D; Ibarz L; De Torres JA; Domenech-Torné FM; Salvador L Rev Esp Oncol; 1984; 31(3):409-14. PubMed ID: 6546169 [TBL] [Abstract][Full Text] [Related]
14. Selective decrease in serum immunoglobulin G1. A tissue nonspecific tumor marker detecting early stages of gynecologic malignant disease with high efficiency. Schauenstein E; Lahousen M; Weblacher M; Steinschifter W; Estelberger W; Schauenstein K Cancer; 1996 Aug; 78(3):511-6. PubMed ID: 8697398 [TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors]. Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744 [No Abstract] [Full Text] [Related]
16. Diagnostic and prognostic value of TPA in breast cancer. Madeddu G; Farris A; Casu AR; Saiu MA; Eriu R; Costanza C; Arras ML; Costanza C; Campus S Cancer Detect Prev; 1985; 8(1-2):47-52. PubMed ID: 4064051 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of different serum tumor markers in gynecological malignancies. Paulick R; Caffier H; Horner G; Lang K; Filbry E Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031 [TBL] [Abstract][Full Text] [Related]
18. [Cytokeratin tumor markers in ovarian carcinoma: tissue polypeptide specific antigen (TPS) and M3/M21]. Hefler L; Tempfer C; Häusler G; Heinzl H; Kainz C Wien Klin Wochenschr; 1998 Oct; 110(18):635-41. PubMed ID: 9816636 [TBL] [Abstract][Full Text] [Related]
19. [Tissue polypeptide antigen in serum and tissue in patients with lung cancer]. Haga E Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Apr; 28(4):595-604. PubMed ID: 2170727 [TBL] [Abstract][Full Text] [Related]
20. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors]. Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]